Govt health spending nearly triples to Rs 3.85 lakh crore; NHA data shows stronger public financing, lower out-of-pocket burden

IMT News Desk
IMT News Desk
· 2 min read
Government health spending in India nearly triples to Rs 3.85 lakh crore in 2022-23, easing out-of-pocket burden and boosting progress toward UHC.

Government expenditure on health in India has nearly tripled over the past decade to Rs 3.85 lakh crore in 2022-23, signalling a steady strengthening of public financing for healthcare and a visible easing of the burden on households, according to the latest National Health Accounts (NHA) estimates released by the Union Health Ministry. The tenth NHA report for 2022-23 shows that government health expenditure has increased from about Rs 1.30 lakh crore in 2013-14, reflecting sustained higher allocations for health at both the Union and state levels and a clear policy push toward universal health coverage and financial protection.

As a share of GDP, government health expenditure has risen from around 1.15 per cent in 2013-14 to 1.43 per cent in 2022-23 on the earlier GDP series, and stands at 1.48 per cent when calculated using the revised series with 2022-23 as the base year, as highlighted in the PIB note. The Health Ministry has underlined that health is also claiming a higher share of the overall government budget, with government health expenditure as a proportion of total government expenditure increasing over the decade, indicating that health is gradually being prioritised within public spending.

The NHA data points to a marked decline in the reliance on out-of-pocket spending, historically one of the biggest sources of financial hardship for Indian households. Out-of-pocket expenditure as a share of total health expenditure has fallen from about 64 per cent in 2013-14 to roughly 43 per cent in 2022-23, while the government’s contribution has increased to around 44 per cent of total health spending in the same period. Per capita government health spending has also risen significantly, roughly 2.5- 2.7 times over the decade, reflecting expanded public provisioning through schemes, programmes and free or subsidised services.

The official communication emphasises that increased government spending has been accompanied by a strategic focus on primary healthcare, with allocations for primary care more than doubling over the reference period. Health policy experts say that while the latest NHA numbers capture meaningful progress in public financing and a reduction in household burden, India will still need to continue raising the health share in total government expenditure and improve the efficiency of spending to move closer to the global benchmark of robust, equitable universal health coverage.

Read Next

PM Modi to Dedicate Key Healthcare Infrastructure Projects to Nation on July 17: PGIMER Director
News
July 14, 2026

PM Modi to Dedicate Key Healthcare Infrastructure Projects to Nation on July 17: PGIMER Director

Prime Minister Narendra Modi will dedicate several key healthcare infrastructure projects to the nation on July 17, according to PGIMER Director Dr Vivek Lal. The projects include the Advanced Mother and Child Centre, the Advanced Neurosciences Centre and a new Critical Care Block, all of which are expected to strengthen tertiary care services and expand […]
Article by: IMT News Desk
OneSource Specialty Pharma and Formycon AG Announce Strategic Manufacturing Partnership for Biosimilars
News
July 14, 2026

OneSource Specialty Pharma and Formycon AG Announce Strategic Manufacturing Partnership for Biosimilars

OneSource Specialty Pharma Limited and Formycon AG have announced a strategic manufacturing partnership for biosimilars, bringing together Formycon’s biosimilar development expertise and OneSource’s integrated biologics manufacturing capabilities to support global markets. Under the agreement, OneSource will serve as a strategic manufacturing partner for Formycon and provide both drug substance and drug product manufacturing from its […]
Article by: IMT News Desk
FDA Approves At-Home Starter Dose of Eisai-Biogen’s Alzheimer’s Drug Leqembi
News
July 14, 2026

FDA Approves At-Home Starter Dose of Eisai-Biogen’s Alzheimer’s Drug Leqembi

The U.S. Food and Drug Administration has approved an at-home starting dose of Eisai and Biogen’s Alzheimer’s drug Leqembi, allowing some patients to begin treatment with injections administered by themselves or a caregiver. The decision expands access to the drug’s subcutaneous formulation, which can now be used as a starter dose rather than only after […]
Article by: IMT News Desk
Emcure Pharmaceuticals Consolidates Full Ownership of Gennova Amid Leadership Transition
News
July 14, 2026

Emcure Pharmaceuticals Consolidates Full Ownership of Gennova Amid Leadership Transition

Emcure Pharmaceuticals Limited has announced the consolidation of its shareholding in biopharma subsidiary Gennova Biopharmaceuticals Limited, alongside a leadership transition, as it sharpens its focus on biologics and biosimilars. The company is acquiring the entire 12.05% minority stake in Gennova held by Dr Sanjay Singh and others, taking its ownership to 100% and making Gennova […]
Article by: IMT News Desk